Moreover, the AUC indicated that serum GP73 exhibited a potential to differentiate patients at different fibrotic stages in MASLD: the AUC for GP73 to predict significant fibrosis (≥F2), severe fibrosis (≥F3), and cirrhosis (F4) was 0.897, 0.935, and 0.960, respectively. Here, GOLM1 is linked to Cirrhosis.